国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產品名稱 貨號 規格
Recombinant Vesicomyosocius okutanii subsp. Calyptogena okutanii Sec-independent protein translocase protein TatA (tatA), partial CSB-YP399446VDY
CSB-EP399446VDY
CSB-BP399446VDY
CSB-MP399446VDY
CSB-EP399446VDY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vesicomyosocius okutanii subsp. Calyptogena okutanii NADH-quinone oxidoreductase subunit H (nuoH), partial CSB-YP399447VDY
CSB-EP399447VDY
CSB-BP399447VDY
CSB-MP399447VDY
CSB-EP399447VDY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vesicomyosocius okutanii subsp. Calyptogena okutanii 50S ribosomal protein L36 (rpmJ) CSB-YP399448VDY
CSB-EP399448VDY
CSB-BP399448VDY
CSB-MP399448VDY
CSB-EP399448VDY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vesicomyosocius okutanii subsp. Calyptogena okutanii Probable cytosol aminopeptidase (pepA) CSB-YP399449VDY
CSB-EP399449VDY
CSB-BP399449VDY
CSB-MP399449VDY
CSB-EP399449VDY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vesicomyosocius okutanii subsp. Calyptogena okutanii 30S ribosomal protein S19 (rpsS) CSB-YP399450VDY
CSB-EP399450VDY
CSB-BP399450VDY
CSB-MP399450VDY
CSB-EP399450VDY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vesicomyosocius okutanii subsp. Calyptogena okutanii 50S ribosomal protein L5 (rplE) CSB-YP399451VDY
CSB-EP399451VDY
CSB-BP399451VDY
CSB-MP399451VDY
CSB-EP399451VDY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vesicomyosocius okutanii subsp. Calyptogena okutanii 50S ribosomal protein L15 (rplO) CSB-YP399452VDY
CSB-EP399452VDY
CSB-BP399452VDY
CSB-MP399452VDY
CSB-EP399452VDY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vesicomyosocius okutanii subsp. Calyptogena okutanii Sulfate adenylyltransferase (sat) CSB-YP399453VDY
CSB-EP399453VDY
CSB-BP399453VDY
CSB-MP399453VDY
CSB-EP399453VDY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vesicomyosocius okutanii subsp. Calyptogena okutanii ATP-dependent dethiobiotin synthetase BioD (bioD) CSB-YP399454VDY
CSB-EP399454VDY
CSB-BP399454VDY
CSB-MP399454VDY
CSB-EP399454VDY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelotomaculum thermopropionicum Adenylosuccinate synthetase (purA) CSB-YP399455PYG
CSB-EP399455PYG
CSB-BP399455PYG
CSB-MP399455PYG
CSB-EP399455PYG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelotomaculum thermopropionicum UPF0145 protein PTH_2690 (PTH_2690) CSB-YP399456PYG
CSB-EP399456PYG
CSB-BP399456PYG
CSB-MP399456PYG
CSB-EP399456PYG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelotomaculum thermopropionicum Formamidopyrimidine-DNA glycosylase (mutM) CSB-YP399457PYG
CSB-EP399457PYG
CSB-BP399457PYG
CSB-MP399457PYG
CSB-EP399457PYG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelotomaculum thermopropionicum Ribosomal RNA small subunit methyltransferase H (rsmH) CSB-YP399458PYG
CSB-EP399458PYG
CSB-BP399458PYG
CSB-MP399458PYG
CSB-EP399458PYG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelotomaculum thermopropionicum UDP-N-acetylenolpyruvoylglucosamine reductase (murB) CSB-YP399459PYG
CSB-EP399459PYG
CSB-BP399459PYG
CSB-MP399459PYG
CSB-EP399459PYG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelotomaculum thermopropionicum Bifunctional protein pyrR (pyrR) CSB-YP399460PYG
CSB-EP399460PYG
CSB-BP399460PYG
CSB-MP399460PYG
CSB-EP399460PYG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelotomaculum thermopropionicum Dihydroorotase (pyrC) CSB-YP399461PYG
CSB-EP399461PYG
CSB-BP399461PYG
CSB-MP399461PYG
CSB-EP399461PYG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelotomaculum thermopropionicum UPF0296 protein PTH_1796 (PTH_1796) CSB-YP399462PYG
CSB-EP399462PYG
CSB-BP399462PYG
CSB-MP399462PYG
CSB-EP399462PYG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelotomaculum thermopropionicum 5-methylthioadenosine/S-adenosylhomocysteine deaminase (mtaD) CSB-YP399463PYG
CSB-EP399463PYG
CSB-BP399463PYG
CSB-MP399463PYG
CSB-EP399463PYG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelotomaculum thermopropionicum Glycerol-3-phosphate dehydrogenase [NAD (P)+] CSB-YP399464PYG
CSB-EP399464PYG
CSB-BP399464PYG
CSB-MP399464PYG
CSB-EP399464PYG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelotomaculum thermopropionicum Undecaprenyl-diphosphatase (uppP), partial CSB-YP399465PYG
CSB-EP399465PYG
CSB-BP399465PYG
CSB-MP399465PYG
CSB-EP399465PYG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質形式,可以通過多種方式產生大量蛋白質、修改基因序列和制造有用的商業產品。重組蛋白的技術資源在重組蛋白的開發過程中,除了表達系統之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質量的重組蛋白,后續的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據他們開發重組蛋白的經驗總結出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產,在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質合成機制來產生由該基因編碼的蛋白質。表達載體可使外源基因在宿主細胞中高效表達,經過多年的發展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產過程中是一種基本成分。正如標題所示,本文主要總結了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質?

根據重組蛋白的不同應用,對其生物活性有不同的要求。但是我們如何確保蛋白質的產生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質有任何疑問,涉及到蛋白質的價格、交貨、質量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>